ストックスクリーナーアプリを入手
7.78
2.91%
0.22
プレマーケット:
7.88
0.10
+1.29%
Sellas Life Sciences Group Inc (SLS) 最新ニュース
SLS Stock Rallies After Hours As CEO Teases Leukemia Study Data Any Day Now - Stocktwits
SLS stock hits 4-year high: BlackRock stake boost fuels buzz around looming AML trial readout - MSN
SLS Stock Hits Over 4-Year High: CEO Eyes FDA Talks, ‘Whole Gamut’ Of Cancer Uses For GPS - Stocktwits
SLS Stock Tanks Hard: Retail Traders Blame Warrant Holders, 'Flippers' Cashing Out Before AML Catalyst - Stocktwits
Why did ARM, SLS, EBAY stocks surge to 52-week highs? - MSN
SLS stock tanks hard: Retail traders blame warrant holders, 'flippers' cashing out before AML catalyst - MSN
SLS stock pops big after hours on imminent leukemia trial data readout optimism - MSN
SLS stock rallies after hours as CEO teases leukemia study data any day now - MSN
NBIS, CSCO, SLS stocks hit 52-week highs today: What's behind the surge? - MSN
SLS stock hits over 4-year high: CEO eyes FDA talks, ‘whole gamut’ of cancer uses for GPS - MSN
Sellas Life Sciences: REGAL Delay May Be A Warning Sign, Not A Bullish Signal (NASDAQ:SLS) - Seeking Alpha
Assessing SELLAS Life Sciences Group (SLS) Valuation After Strong Multi-Year Returns And A Sharp One-Day Share Price Drop - simplywall.st
SLS stock jumps premarket: CEO says GPS AML data has ‘very good chance’ to beat earlier survival outcomes - MSN
SELLAS Life Sciences Group Down Nearly 19%, on Pace for Largest Percent Decrease Since March 2024 -- Data Talk - Moomoo
SLS Stock Pulls Back As Cash Pile Extends Biotech Runway - StocksToTrade
SLS Stock Jumps Premarket: CEO Says GPS AML Data Has ‘Very Good Chance’ To Beat Earlier Survival Outcomes - Stocktwits
Why Did ARM, SLS, EBAY Stocks Surge To 52-Week Highs? - Stocktwits
SLS: Pivotal data for GPS and SLS-009 in AML expected by year-end, backed by strong financials - TradingView
SLS Stock Jumps As Cash Pile Grows And Trial Catalysts Near - StocksToTrade
SLS Stock Jumps As SELLAS Boosts Cash And Near-Term Catalysts - timothysykes.com
SELLAS Life Sciences Stock Is Surging Wednesday: What's Driving The Move? - Benzinga
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus - TechStock²
SLS: Imminent phase III and II data for GPS and SLS009 in AML signal major near-term catalysts - TradingView
SLS: GPS and SLS-009 advance in AML, with pivotal data and biomarker-driven expansion expected soon - TradingView
SLS Technical Analysis | Trend, Signals & Chart Patterns | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - ChartMill
SLS stock heads for weekly win: Deutsche Bank’s stake boost draws attention ahead of Q1 earnings - MSN
SLS Stock Price, Quote & Chart | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - ChartMill
SELLAS Life Sciences (SLS) Nears Pivotal AML Data as Cash, Pipeline and ATM Plan Reframe Its Story - simplywall.st
SLS on track to clock best week in over 4 months: Retail divided between stock drop or multibagger status amid upcoming leukemia trial readout - MSN
SELLAS Life Sciences Group (SLS) price target increased by 15.38% to 10.20 - MSN
SELLAS Life Sciences Group, Inc.Common Stock (NQ: SLS - FinancialContent
SLS Stock Surges Into Conference Season As Investors Hunt For AML Readout Hints - Stocktwits
Wall Street Analysts Believe SELLAS Life Sciences Group, Inc. (SLS) Could Rally 63.58%: Here's is How to Trade - MSN
SLS Stock Pops Big After Hours On Imminent Leukemia Trial Data Readout Optimism - Stocktwits
SLS Stock Hits 4-Year High: BlackRock Stake Boost Fuels Buzz Around Looming AML Trial Readout - Stocktwits
SLS stock surges into conference season as investors hunt for AML readout hints - MSN
SELLAS Nears Key AML Data As Dual Trials Shape High-Risk Outlook - simplywall.st
2.98%
1.33%
大文字化:
|
ボリューム (24 時間):